HCPLive Network


Latest Issue
Other Issues
Study Shows Opioid Agonist Therapy May Prevent Spread of Hepatitis C Among Young Injection Drug Users
By Catherine Kolonko
Researchers have found that maintenance treatment with methadone or buprenorphine may help prevent hepatitis C infection among injection drug users, a population with the highest risk of infection of the virus.
Researchers Grow Human Norovirus Culture
By Jacquelyn Gray
Hoping their discovery will lead to novel treatments, University of Florida researchers have successfully manufactured the human norovirus in a cell culture dish.
Age-related Diseases Don’t Occur Earlier in HIV-infected Patients
By Jacquelyn Gray
Despite previous research suggesting HIV patients have an increased likelihood of suffering from a heart attack, kidney failure, or cancer, Johns Hopkins Bloomberg School of Public Health investigators showed the age they encounter these conditions were similar to their uninfected counterparts.
Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B
By Kari Oakes, PA-C
Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Diarrhea Superbug Infections Double
By Jacquelyn Gray
From 2001 to 2010, the infection rate of a particular intestinal "superbug" has doubled, with increases in mortality rates and length of hospital stays reflecting this trend.
DNA Sequencing Could Lead to More Accurate Pneumonia Diagnosis
By Jacquelyn Gray
A team of researchers at George Washington University has reported that next-generation sequencing of sputum samples taken from patients in the intensive care unit can accurately identify the strain of ventilator-associated pneumonia a patient is infected with.
New Line of HIV Treatment Identified for Patients Ineligible for Efavirenz
By Jacquelyn Gray
A national clinical trial has found non-efavirenz antiretroviral therapy effective as a first-line treatment, which is good news for patients with HIV who are ineligible to use the common drug.
New Study Provides Hope for Chronic Lyme Disease Sufferers
By Adam Hochron
Patients with Lyme disease know that their symptoms and the effects of the disease can be debilitating and last for a long time, often persisting even after treatment.
Triple Therapy for Hepatitis C Infection: Bacterial Infection Risk Rises, Changes
By Jeannette Y. Wick, RPh, MBA, FASCP
Patients who have HCV infection are at high risk for arthralgia, myalgias, pruritus, neuropathy, and decompensated livers. Until recently the sole available treatment was interferon. After the US Food and Drug Administration (FDA) approved ribavirin, patients who took ribavirin plus interferon responded better. Now, the FDA has approved a small selection of oral antivirals to treat hepatitis C.